Single‐cell RNA sequencing (scRNA‐seq) has provided valuable insights into the intricate interactions within the TME of EGFR‐TKI‐resistant NSCLC, particularly regarding the resistance mechanisms to combination therapies like atezolizumab and bevacizumab. Here, EGFR is linked to non-small cell lung carcinoma.